195 related articles for article (PubMed ID: 32036211)
1. The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage.
Mei C; Lei L; Tan LM; Xu XJ; He BM; Luo C; Yin JY; Li X; Zhang W; Zhou HH; Liu ZQ
Biomed Pharmacother; 2020 May; 125():109875. PubMed ID: 32036211
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
Tomicic MT; Kaina B
Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
[TBL] [Abstract][Full Text] [Related]
3. DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.
Cristini A; Park JH; Capranico G; Legube G; Favre G; Sordet O
Nucleic Acids Res; 2016 Feb; 44(3):1161-78. PubMed ID: 26578593
[TBL] [Abstract][Full Text] [Related]
4. Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin.
El-Khamisy SF; Katyal S; Patel P; Ju L; McKinnon PJ; Caldecott KW
DNA Repair (Amst); 2009 Jun; 8(6):760-6. PubMed ID: 19303373
[TBL] [Abstract][Full Text] [Related]
5. Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage.
Adachi N; So S; Koyama H
J Biol Chem; 2004 Sep; 279(36):37343-8. PubMed ID: 15218034
[TBL] [Abstract][Full Text] [Related]
6. Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.
Maede Y; Shimizu H; Fukushima T; Kogame T; Nakamura T; Miki T; Takeda S; Pommier Y; Murai J
Mol Cancer Ther; 2014 Jan; 13(1):214-20. PubMed ID: 24130054
[TBL] [Abstract][Full Text] [Related]
7. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.
Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I
BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818
[TBL] [Abstract][Full Text] [Related]
9. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
10. DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors.
Pommier Y; Jenkins J; Kohlhagen G; Leteurtre F
Mutat Res; 1995 Sep; 337(2):135-45. PubMed ID: 7565862
[TBL] [Abstract][Full Text] [Related]
11. Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin.
Wu J; Yin MB; Hapke G; Tóth K; Rustum YM
Mol Pharmacol; 2002 Apr; 61(4):742-8. PubMed ID: 11901212
[TBL] [Abstract][Full Text] [Related]
12. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1.
El-Khamisy SF; Saifi GM; Weinfeld M; Johansson F; Helleday T; Lupski JR; Caldecott KW
Nature; 2005 Mar; 434(7029):108-13. PubMed ID: 15744309
[TBL] [Abstract][Full Text] [Related]
13. The distinctive cellular responses to DNA strand breaks caused by a DNA topoisomerase I poison in conjunction with DNA replication and RNA transcription.
Sakasai R; Iwabuchi K
Genes Genet Syst; 2016; 90(4):187-94. PubMed ID: 26616758
[TBL] [Abstract][Full Text] [Related]
14. Camptothecin Efficacy to Poison Top1 Is Altered by Bisphenol A in Mouse Embryonic Fibroblasts.
Sonavane M; Sykora P; Andrews JF; Sobol RW; Gassman NR
Chem Res Toxicol; 2018 Jun; 31(6):510-519. PubMed ID: 29799191
[TBL] [Abstract][Full Text] [Related]
15. TDP1-independent pathways in the process and repair of TOP1-induced DNA damage.
Zhang H; Xiong Y; Su D; Wang C; Srivastava M; Tang M; Feng X; Huang M; Chen Z; Chen J
Nat Commun; 2022 Jul; 13(1):4240. PubMed ID: 35869071
[TBL] [Abstract][Full Text] [Related]
16. New Topoisomerase I mutations are associated with resistance to camptothecin.
Gongora C; Vezzio-Vie N; Tuduri S; Denis V; Causse A; Auzanneau C; Collod-Beroud G; Coquelle A; Pasero P; Pourquier P; Martineau P; Del Rio M
Mol Cancer; 2011 May; 10():64. PubMed ID: 21619602
[TBL] [Abstract][Full Text] [Related]
17. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
[TBL] [Abstract][Full Text] [Related]
18. Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition.
Perego P; Cossa G; Tinelli S; Corna E; Carenini N; Gatti L; De Cesare M; Ciusani E; Zunino F; Luison E; Canevari S; Zaffaroni N; Beretta GL
Biochem Pharmacol; 2012 Jan; 83(1):27-36. PubMed ID: 21978643
[TBL] [Abstract][Full Text] [Related]
19. PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin.
Mouly L; Mamouni K; Gence R; Cristini A; Cherier J; Castinel A; Legrand M; Favre G; Sordet O; Monferran S
Cell Death Dis; 2018 Sep; 9(9):931. PubMed ID: 30209297
[TBL] [Abstract][Full Text] [Related]
20. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.
Tanizawa A; Kohn KW; Kohlhagen G; Leteurtre F; Pommier Y
Biochemistry; 1995 May; 34(21):7200-6. PubMed ID: 7766631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
